Developer docs
API playgroundTry for free, no card

Search company profiles

Respiratory Motion

Full company profile

uuid0000qjk

Namestring
Respiratory Motion
Legal namestring
PRAGMATIC138
Company typeenum
Private
Founded yearint
2026
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWatertown, United States
HQ citystring
Watertown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
respiratory monitoring, medical devices, patient monitoring, ventilation measurement, clinical diagnostics
Industry3 codes
1Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry)
CodeHLAHACADPrimaryYes
2Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
CodeHLAKANAMPrimaryNo
3Pulmonary Function Testing (PFT) & Spirometry Equipment
CodeHLAHAGAHPrimaryNo
Product category
Respiratory Monitoring Devices
Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Respiratory Motion is a commercial-stage medical device company that develops non-invasive respiratory monitoring technology for clinical use. The company's products measure and monitor patient breathing parameters to help healthcare providers detect and manage respiratory compromise in hospital and post-operative care settings.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The website at respiratorymotion.com contains content for PRAGMATIC138, an online gambling platform. The platform offers multiple gaming categories including slot games, sports betting, live casino, and lottery games. This content does not appear to be related to Respiratory Motion, a respiratory monitoring medical device company - the domain appears to host unrelated content. No medical device products or services are present in the scraped data.

Product and service1 record
1Respiratory Monitoring Device
CategoryPatient Monitoring
Description

Non-invasive medical device for continuous monitoring of patient respiratory parameters in clinical settings, used by hospitals and healthcare providers to detect respiratory compromise and support clinical decision-making.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Masimo is a leading non-invasive patient monitoring company with deep expertise in pulse oximetry, capnography, and respiratory monitoring — directly overlapping with Respiratory Motion's core monitoring franchise and competing for similar hospital clinical workflows.

TypeDirect peer
Description

Dräger is a major global provider of respiratory monitoring, anesthesia, and ventilation equipment, directly comparable to Respiratory Motion's respiratory monitoring positioning in the hospital and critical care setting.

TypeBroad incumbent
Description

Medtronic offers capnography and integrated patient monitoring solutions (including the INVOS and Microstream portfolios) as part of its broader medtech portfolio, overlapping with respiratory monitoring in hospitals and procedural sedation use cases.

TypeBroad incumbent
Description

Philips Patient Monitoring portfolio includes continuous respiration, capnography, and integrated bedside monitoring — a broad incumbent competitor that competes for the same hospital purchasing budgets and clinical workflows.

TypeBroad incumbent
Description

GE HealthCare's patient monitoring solutions include respiratory parameter monitoring integrated into its bedside and transport monitors, making it a broad incumbent competing for hospital system contracts.

TypeDirect peer
Description

Nonin Medical specializes in pulse oximetry and capnography sensors and monitors, directly comparable to Respiratory Motion's non-invasive respiratory monitoring focus and targeting similar clinical customers.

TypeEmerging player
Description

Mindray offers patient monitoring and respiratory monitoring devices at competitive price points, increasingly penetrating the U.S. hospital market and competing on integrated multi-parameter monitoring solutions.

TypeDirect peer
Description

Nihon Kohden develops multi-parameter patient monitoring with strong respiratory monitoring capabilities, directly comparable in clinical use case and target customer profile to Respiratory Motion.

TypeBroad incumbent
Description

ResMed is the dominant player in sleep-disordered breathing and ventilation, with overlapping respiratory monitoring technology applicable to both hospital and home care settings adjacent to Respiratory Motion's space.

TypeDirect peer
Description

Hamilton Medical specializes in mechanical ventilation and respiratory monitoring, directly comparable in clinical focus on respiratory assessment, ventilation decision support, and ICU workflow integration.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds12 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors18 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Respiratory Motion

Respiratory Monitoring Devicesrespiratorymotion.com

Respiratory Motion firmographics

Firmographics
Name
Respiratory Motion
Legal name
PRAGMATIC138
Website
https://respiratorymotion.com
Company type
Private
Founded year
2026
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Respiratory Motion industry classification

Industry
Product category
Respiratory Monitoring Devices
akta.pro primary industry
Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD)
akta.pro secondary industries
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM), Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH)

Keywords

  • Respiratory monitoring
  • Medical devices
  • Patient monitoring
  • Ventilation measurement
  • Clinical diagnostics

Where Respiratory Motion is headquartered

Location

Headquarters

HQ city
Watertown
HQ country
United States
HQ region
North America

Markets served

Respiratory Motion business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Respiratory Motion product offering

Product offering

Core offering

Respiratory Motion is a commercial-stage medical device company that develops non-invasive respiratory monitoring technology for clinical use. The company's products measure and monitor patient breathing parameters to help healthcare providers detect and manage respiratory compromise in hospital and post-operative care settings.

Product overview

The website at respiratorymotion.com contains content for PRAGMATIC138, an online gambling platform. The platform offers multiple gaming categories including slot games, sports betting, live casino, and lottery games. This content does not appear to be related to Respiratory Motion, a respiratory monitoring medical device company - the domain appears to host unrelated content. No medical device products or services are present in the scraped data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Respiratory Monitoring Device Non-invasive medical device for continuous monitoring of patient respiratory parameters in clinical settings, used by hospitals and healthcare providers to detect respiratory compromise and support clinical decision-making.

Companies that use Respiratory Motion

Customer profile

Ideal customer profiles1 record

Respiratory Motion technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Respiratory Motion partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights3 records

Respiratory Motion competitors and assessment

Company assessment

Direct peers

  • Masimo: Masimo is a leading non-invasive patient monitoring company with deep expertise in pulse oximetry, capnography, and respiratory monitoring — directly overlapping with Respiratory Motion's core monitoring franchise and competing for similar hospital clinical workflows.
  • Dräger: Dräger is a major global provider of respiratory monitoring, anesthesia, and ventilation equipment, directly comparable to Respiratory Motion's respiratory monitoring positioning in the hospital and critical care setting.
  • Nonin Medical: Nonin Medical specializes in pulse oximetry and capnography sensors and monitors, directly comparable to Respiratory Motion's non-invasive respiratory monitoring focus and targeting similar clinical customers.
  • Nihon Kohden: Nihon Kohden develops multi-parameter patient monitoring with strong respiratory monitoring capabilities, directly comparable in clinical use case and target customer profile to Respiratory Motion.
  • Hamilton Medical: Hamilton Medical specializes in mechanical ventilation and respiratory monitoring, directly comparable in clinical focus on respiratory assessment, ventilation decision support, and ICU workflow integration.

Broad incumbents

  • Medtronic: Medtronic offers capnography and integrated patient monitoring solutions (including the INVOS and Microstream portfolios) as part of its broader medtech portfolio, overlapping with respiratory monitoring in hospitals and procedural sedation use cases.
  • Philips: Philips Patient Monitoring portfolio includes continuous respiration, capnography, and integrated bedside monitoring — a broad incumbent competitor that competes for the same hospital purchasing budgets and clinical workflows.
  • GE HealthCare: GE HealthCare's patient monitoring solutions include respiratory parameter monitoring integrated into its bedside and transport monitors, making it a broad incumbent competing for hospital system contracts.
  • ResMed: ResMed is the dominant player in sleep-disordered breathing and ventilation, with overlapping respiratory monitoring technology applicable to both hospital and home care settings adjacent to Respiratory Motion's space.

Emerging players

  • Mindray: Mindray offers patient monitoring and respiratory monitoring devices at competitive price points, increasingly penetrating the U.S. hospital market and competing on integrated multi-parameter monitoring solutions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Respiratory Motion social profiles

Digital presence

Respiratory Motion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Respiratory Motion leadership team

Management profile

Number of profiles

Profiles8 records

Respiratory Motion funding detail

Funding detail

Funding overview

Funding rounds12 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Respiratory Motion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Respiratory Motion

What does Respiratory Motion do?

Respiratory Motion is a commercial-stage medical device company that develops non-invasive respiratory monitoring technology for clinical use. The company's products measure and monitor patient breathing parameters to help healthcare providers detect and manage respiratory compromise in hospital and post-operative care settings.

Is Respiratory Motion a public or private company?

Respiratory Motion is a private company. It is classified as venture growth investor backed and is currently operating.

When was Respiratory Motion founded?

Respiratory Motion was founded in 2026. It employs 11 to 50 people.

Where is Respiratory Motion based?

Respiratory Motion is headquartered in Watertown, United States, in the North America region.

Who are Respiratory Motion's main competitors?

Direct peers on record are Masimo, Dräger, Nonin Medical, Nihon Kohden and Hamilton Medical. Broad incumbents are Medtronic, Philips, GE HealthCare and ResMed. Mindray is listed as an emerging player.

Does Respiratory Motion have an API?

No public API is recorded for Respiratory Motion.

What industry is Respiratory Motion in?

Respiratory Motion's product category is Respiratory Monitoring Devices. Its primary akta.pro industry code is HLAHACAD, Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry), with a secondary code of HLAKANAM, Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMarket Trend Insights: The Impact of Recent Advances on the Respiratory Monitoring Devices MarketThe respiratory monitoring devices market is projected to reach $2.89 billion by 2030, growing at a compound annual growth rate of 9.8%, driven by rising adoption of remote patient monitoring solutions and AI-driven clinical decision support systems. In March 2023, VitalConnect acquired Entelechon, a Germany-based company specializing in respiratory monitoring devices, for $100 million to strengthen VitalConnect's position in the digital health market through advanced ingestible sensor technologies. In December 2023, Adherium Ltd. launched its Hailie Smartinhaler in the U.S. market, a next-generation device that converts standard pressurized metered-dose inhalers into connected smart inhalers for asthma and COPD patients.SenzimeSenzime completes the acquisition of Respiratory Motion and issues 2,127,537 new sharesSenzime completed the acquisition of Respiratory Motion and issued 2,127,537 new shares as part of the transaction. The press release was issued from Uppsala on July 1, 2022, with standard legal restrictions on distribution in various jurisdictions.SenzimeSenzime has entered into an agreement to acquire the US company Respiratory MotionSenzime has entered into an agreement to acquire 100 percent of the shares in US-based Respiratory Motion for an initial consideration of USD 19 million, with a potential earn-out of up to USD 25 million. The acquisition aims to expand Senzime's product portfolio by adding Respiratory Motion's ExSpiron system, thereby extending its capabilities to monitor vital signs outside the operating room and accelerating market penetration through synergies.MarketScreenerSenzime has entered into an agreement to acquire the US company Respiratory MotionSenzime AB has entered into an agreement to acquire 100 percent of the shares in US-based Respiratory Motion, Inc. for an initial consideration of USD 19 million, with a potential earn-out of up to USD 25 million. The acquisition aims to expand Senzime's product portfolio by adding Respiratory Motion's ExSpiron system, enabling cross-selling synergies and accelerating market penetration in patient monitoring outside the operating room.PR NewswireRespiratory Motion releases ExSpiron2XiRespiratory Motion, a medical device company based in Watertown, Massachusetts, announced the launch of its new digital ExSpiron2Xi respiratory monitoring platform on April 29, 2021. The ExSpiron2Xi is the first new product launch by the company since Fall 2017, representing a digital enhancement of their existing standalone respiratory volume monitoring technology. The device is designed to assist healthcare providers globally in assessing respiratory status and providing early warning of respiratory collapse.PR NewswireRespiratory Motion Debuts New Corporate Brand Affirming Commitment to Inspired Innovation that Enhances A Safer And More Cost-effective Platform Of Patient Care.Respiratory Motion announced the launch of a new corporate brand identity, including a modified logo and tagline, to emphasize its commitment to innovation in non-invasive respiratory volume monitoring. The company aims to expand its market presence beyond traditional post-operative settings by highlighting a broader portfolio of breathing solutions for various healthcare environments. This rebranding is intended to enhance brand awareness and reinforce values such as reliability and discovery.PR NewswireC. Raymond Larkin to be Strategic Advisor at Respiratory Motion, Inc.Respiratory Motion Inc. announced that C. Raymond Larkin Jr. will serve as Strategic Advisor to the company, effective immediately. Larkin previously served as President and CEO of Nellcor Puritan Bennett Inc., where he led the company to nearly $1 billion in revenues over 15 years through the development of pulse oximetry technology. The appointment aims to strengthen RMI's strategic direction in respiratory monitoring technology and patient care improvement.PR NewswireLaura Piccinini Named as Chief Executive Officer at Respiratory Motion, Inc.Respiratory Motion, Inc. appointed Laura Piccinini as its new Chief Executive Officer effective July 14, 2020, succeeding founder Dr. Jenny Freeman. Piccinini, who joined the board in 2020, brings extensive executive experience from major medical device firms including Envista and Danaher. The leadership change aims to leverage her commercial acumen to drive sustainable growth and profitability for the respiratory monitoring company.PR NewswireRespiratory Motion Inc., is excited to announce the launch of the latest ExSpiron 1Xi™ Respiratory MonitorRespiratory Motion, Inc. announced the launch of its ExSpiron 1Xi Minute Ventilation Monitor following FDA 510(k) clearance, representing the first and only non-invasive device providing continuous minute ventilation measurements without requiring calibration. The monitor enables rapid assessment of breathing in various clinical and field settings, addressing respiratory failure which is the third most prevalent cause of death in the US and the growing problem of opioid-induced respiratory depression. The device will be showcased at the American Society of Anesthesiologists conference in Boston, October 21-25, 2017.PR NewswireRespiratory Motion Receives CE Mark for ExSpiron™Respiratory Motion, Inc. has received CE Mark approval for its ExSpiron patient monitor, which provides Minute Ventilation measurement for patients on mechanical ventilators. The device is the only medical monitor capable of providing this measurement, enabling clinicians to detect respiratory compromise and titrate opioid dosing more effectively. The ExSpiron was previously introduced to European clinicians through presentations at the Deutscher Anesthesia Congress in April, where findings from five studies demonstrated its utility in PACUs, General Wards, and procedural sedation cases.